New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...

New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...

IgA nephropathy (IgAN ... A recent Phase II trial revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, helps to reduce proteinuria and maintain patients' kidney function.

1 the definition of clinically significant antiphospholipid-antibody positivity is not well established, and thrombosis is generally multifactorial. Our objectives are to help both general ...

In autoimmune diseases, the immune system wrongly identifies its “enemy”, and produces antibodies that attack the patient’s own cells. One of these diseases, the anti-phospholipid antibody syndrome ...